Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$513K Hold
18,275
0.26% 75
2025
Q4
$455K Buy
18,275
+750
+4% +$18.9K 0.24% 80
2025
Q3
$447K Sell
17,525
-690
-4% -$17K 0.24% 81
2025
Q2
$442K Buy
18,215
+1,145
+7% +$26.7K 0.25% 83
2025
Q1
$433K Sell
17,070
-777
-4% -$20.3K 0.28% 79
2024
Q4
$473K Buy
17,847
+361
+2% +$9.79K 0.32% 72
2024
Q3
$506K Sell
17,486
-400
-2% -$11.7K 0.35% 61
2024
Q2
$500K Buy
17,886
+3,825
+27% +$105K 0.37% 59
2024
Q1
$390K Buy
14,061
+303
+2% +$8.41K 0.3% 79
2023
Q4
$396K Sell
13,758
-3,740
-21% -$113K 0.31% 71
2023
Q3
$580K Sell
17,498
-100
-0.6% -$3.54K 0.51% 44
2023
Q2
$645K Sell
17,598
-300
-2% -$11.7K 0.53% 45
2023
Q1
$730K Buy
17,898
+1,888
+12% +$81.5K 0.63% 39
2022
Q4
$820K Sell
16,010
-200
-1% -$9.59K 0.69% 38
2022
Q3
$709K Buy
16,210
+1,300
+9% +$63.2K 0.64% 39
2022
Q2
$782K Buy
14,910
+982
+7% +$50K 0.74% 32
2022
Q1
$721K Sell
13,928
-45
-0.3% -$2.33K 0.66% 33
2021
Q4
$825K Sell
13,973
-2,146
-13% -$106K 0.72% 31
2021
Q3
$694K Buy
+16,119
New +$714K 0.66% 36
2021
Q1
$560K Buy
+15,461
New +$549K 0.55% 42

Other funds holding PFE

First Bancorp's PFE Position: Q1 2026 in Review

First Bancorp held its Pfizer (PFE) position steady in Q1 2026 at 18,275 shares worth $513K. The position accounts for 0.26% of the portfolio, ranked #75.

First Bancorp first reported a position in PFE in Q1 2021 and has held it in 20 quarters since. The position peaked at $825K in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • First Bancorp held 18,275 shares of Pfizer worth $513K as of Q1 2026.
  • First Bancorp left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.26% of First Bancorp's portfolio in Q1 2026, its #75 holding.
  • First Bancorp first reported a position in Pfizer in Q1 2021 and has held it in 20 quarters since.
  • First Bancorp's Pfizer position peaked at $825K in Q4 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on First Bancorp's 13F filing for Q1 2026, filed 20 Apr 2026.